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Abstract 
In the setting of acute iliocaval thrombosis due to reversible causes, thrombus removal is 
preferred by many in the management of inferior vena cava (IVC) thrombosis as it is thought likely to 
minimize the long-term complications of chronic venous insufficiency and post-thrombotic syndrome. 
When catheter-directed thrombolysis is not a viable or effective option, the treatment options are limited. 
We present the case of a 56-year-old hospitalized patient with a permanent IVC filter that had been 
inserted 10 years prior at an outside hospital with severe, incapacitating right leg swelling for which 
amputation was considered. The patient underwent suction thrombectomy after failure of thrombolysis. 
The patient’s presenting symptoms of right lower extremity swelling and pain improved upon discharge. 
In our single case, unassisted suction thrombectomy with percutaneously placed cannulae is an effective 
and safe method for the treatment of permanent IVC filter-related iliocaval thrombosis in cases refractory 
to catheter-directed thrombolysis. 
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Introduction 
In the setting of acute iliocaval thrombosis due to reversible causes, thrombus removal is 
preferred by many in the management of IVC thrombosis as it is thought likely to minimize the long-term 
complications of chronic venous insufficiency (CVI) and post-thrombotic syndrome (PTS).1 Systemic 
therapies for acute iliocaval thrombosis do not rapidly remove thrombus burden.2 The majority of reports 
suggest that thrombolytic therapy, delivered locally using catheter-directed thrombolysis (CDT; with or 
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without a pulse-spray and/or a pharmacomechanical adjunct), should be administered as soon as possible 
after the patient becomes symptomatic and ideally within 14 days of onset of symptoms to minimize the 
risk of CVI and PTS.1-3 When catheter-directed thrombolysis is not a viable or effective option, the 
treatment options are limited. AngioVac (AngioDynamics) is a suction thrombectomy device FDA 
approved for “removal of undesirable intravascular material.”4 Limited peer-reviewed data are available 
on its percutaneous application in the management of iliocaval thrombus. We describe the case of a 
patient with severe leg swelling and permanent filter-related iliocaval thrombosis who was treated 
successfully with unassisted percutaneously inserted AngioVac suction thrombectomy. 
Case Presentation 
A 56-year-old hospitalized patient with a permanent Venatech IVC filter that had been inserted 
10 years prior at an outside hospital presented to our service with severe, incapacitating right leg swelling 
for which amputation was considered. The patient has a surgical history of an occluded left-to-right 
femoral-femoral venous bypass for chronic left external iliac and common femoral occlusive venous 
thrombosis. Ultrasound and venography showed acute right lower extremity thrombosis and iliocaval 
occlusive thrombosis involving the IVC filter. 
Treatment 
Through access in the right posterior tibial and femoral veins, the patient underwent 2 sessions of 
catheter-directed alteplase thrombolysis (total rate 0.5mg/hr) and heparin infusions (500 U/hr). Lysis was 
hampered by 2 interruptions for long intervals due to hypofibrinogenemia (exacting multiple transfusions 
of cryoprecipitate). Catheter-directed lysis was eventually terminated after 2 days due to lytic stagnation. 
In the interventional radiology suite, angioplasty of the thrombosed IVC filter with a 14 mm Atlas balloon 
(Bard) was performed to allow for the passage of a 22 Fr AngioVac suction device into the suprarenal 
IVC (via a percutaneously introduced 26 Fr right femoral vein sheath). With the assistance of the 
perfusionist, the AngioVac femoral vein cannula was coupled to the AngioVac venovenous bypass device 
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where the blood is filtered, anticoagulated, and returned to the patient via a percutaneously inserted 18 Fr 
right internal jugular AngioVac inflow sheath (tip at the right atrium). The femoral outflow sheath was 
slowly retracted under continuous AngioVac suction. Large amounts of chronic-appearing thrombus were 
trapped in the filter as shown in Figures 1 and 2. The femoral and jugular cannulae and sheaths were 
removed and hemostasis was achieved with 20 minutes of manual pressure. Activated clotting time was 
kept above 300. 
Results 
Post-AngioVac suction thrombectomy images demonstrate near complete evacuation of thrombus 
material and restoration of ante-grade flow within the inferior vena cava, right common iliac vein, and 
right external iliac vein as shown in Figures 3 and 4. The patient’s presenting symptoms of right lower 
extremity swelling and pain improved upon discharge. 
Conclusion 
In our single case, unassisted AngioVac suction thrombectomy with percutaneously placed cannulae is an 
effective and safe method for the treatment of permanent IVC filter-related iliocaval thrombosis in cases 
refractory to catheter-directed thrombolysis. 
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Figure 1. Suctioned thrombus 
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Figure 2. Angiovac filter with suctioned thrombus 
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Figure 3. Inferior cavogram prior to suction thrombectomy 
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Figure 4. Improved flow in the inferior vena cava post suction thrombectomy. 
 
